A citation-based method for searching scientific literature

Emma-Anne Karlsen, Sam Kahler, Joan Tefay, Shannon R Joseph, Fiona Simpson. Cells 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.
Craig C Hofmeister, Xiaoxia Yang, Flavia Pichiorri, Ping Chen, Darlene M Rozewski, Amy J Johnson, Seungsoo Lee, Zhongfa Liu, Celia L Garr, Erinn M Hade,[...]. J Clin Oncol 2011
62
50

ABCG2 expression, function, and promoter methylation in human multiple myeloma.
Joel G Turner, Jana L Gump, Chunchun Zhang, James M Cook, Douglas Marchion, Lori Hazlehurst, Pamela Munster, Michael J Schell, William S Dalton, Daniel M Sullivan. Blood 2006
126
50


Understanding and targeting resistance mechanisms in NSCLC.
Julia Rotow, Trever G Bivona. Nat Rev Cancer 2017
374
50


Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles.
María L Cuestas, Amalia I Castillo, Alejandro Sosnik, Verónica L Mathet. Bioorg Med Chem Lett 2012
35
50

Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients.
Clara Lemos, Elisa Giovannetti, Paolo A Zucali, Yehuda G Assaraf, George L Scheffer, Tahar van der Straaten, Armida D'Incecco, Alfredo Falcone, Henk-Jan Guchelaar, Romano Danesi,[...]. Pharmacogenomics 2011
49
50

Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.
Adarsh Vennepureddy, Jean-Paul Atallah, Terenig Terjanian. World J Oncol 2015
8
50

Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
Robert W Robey, Tomasz Obrzut, Suneet Shukla, Orsolya Polgar, Sira Macalou, Julian C Bahr, Attilio Di Pietro, Suresh V Ambudkar, Susan E Bates. Cancer Chemother Pharmacol 2009
15
50

UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells.
Yan Wu, Dan Jin, Xiaohong Wang, Jing Du, Weihua Di, Jiajia An, Cuijie Shao, Jiwei Guo. J Oncol 2019
21
50

Non-Small-Cell Lung Cancer: New Rare Targets-New Targeted Therapies-State of The Art and Future Directions.
Katarzyna Stencel, Izabela Chmielewska, Janusz Milanowski, Rodryg Ramlau. Cancers (Basel) 2021
7
50

Revisiting the role of ABC transporters in multidrug-resistant cancer.
Robert W Robey, Kristen M Pluchino, Matthew D Hall, Antonio T Fojo, Susan E Bates, Michael M Gottesman. Nat Rev Cancer 2018
561
50

Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.
Chung-Pu Wu, Anna Maria Calcagno, Suresh V Ambudkar. Curr Mol Pharmacol 2008
173
50

Breast cancer resistance protein (BCRP) affected acquired resistance to gefitinib in a "never-smoked" female patient with advanced non-small cell lung cancer.
J Usuda, T Ohira, Y Suga, T Oikawa, S Ichinose, T Inoue, K Ohtani, S Maehara, K Imai, M Kubota,[...]. Lung Cancer 2007
28
50

BCRP mRNA expression v. clinical outcome in 40 adult AML patients.
Bertil Uggla, Elisabet Ståhl, Dick Wågsäter, Christer Paul, Mats G Karlsson, Allan Sirsjö, Ulf Tidefelt. Leuk Res 2005
72
50

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.
N Masuda, M Fukuoka, M Takada, Y Kusunoki, S Negoro, K Matsui, S Kudoh, N Takifuji, K Nakagawa, S Kishimoto. J Clin Oncol 1992
158
50


Sophoraflavanone G from Sophora flavescens induces apoptosis in triple-negative breast cancer cells.
Wen-Chung Huang, Pei-Yu Gu, Li-Wen Fang, Yu-Ling Huang, Chwan-Fwu Lin, Chian-Jiun Liou. Phytomedicine 2019
7
50

A high-throughput cell-based assay for inhibitors of ABCG2 activity.
Curtis J Henrich, Heidi R Bokesch, Michael Dean, Susan E Bates, Robert W Robey, Ekaterina I Goncharova, Jennifer A Wilson, James B McMahon. J Biomol Screen 2006
98
50

Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter.
Chung-Pu Wu, Suneet Shukla, Anna Maria Calcagno, Matthew D Hall, Michael M Gottesman, Suresh V Ambudkar. Mol Cancer Ther 2007
70
50

Natural Products for Cancer Prevention: Clinical Update 2016.
Kathleen Sanders, Zelda Moran, Zaixing Shi, Rachel Paul, Heather Greenlee. Semin Oncol Nurs 2016
21
50

Anti-MRSA activity of sophoraflavanone G and synergism with other antibacterial agents.
Y Sakagami, M Mimura, K Kajimura, H Yokoyama, M Linuma, T Tanaka, M Ohyama. Lett Appl Microbiol 1998
18
50

Cytotoxic lavandulyl flavanones from Sophora flavescens.
T H Kang, S J Jeong, W G Ko, N Y Kim, B H Lee, M Inagaki, T Miyamoto, R Higuchi, Y C Kim. J Nat Prod 2000
88
50

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.
R W Robey, Y Honjo, K Morisaki, T A Nadjem, S Runge, M Risbood, M S Poruchynsky, S E Bates. Br J Cancer 2003
270
50

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
50

Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways.
Chao Guo, Lei Yang, Chuan-Xing Wan, Yuan-Zheng Xia, Chao Zhang, Meng-Han Chen, Zhen-Dong Wang, Zhong-Rui Li, Xue-Mei Li, Ya-Di Geng,[...]. Phytomedicine 2016
53
50

Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.
D W Shen, A Fojo, J E Chin, I B Roninson, N Richert, I Pastan, M M Gottesman. Science 1986
611
50

The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.
Karthika Natarajan, Jasjeet Bhullar, Suneet Shukla, Mehmet Burcu, Zhe-Sheng Chen, Suresh V Ambudkar, Maria R Baer. Biochem Pharmacol 2013
56
50

Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs.
Byung-Hak Kim, Cheolhee Won, Yun-Han Lee, Jung Sook Choi, Kum Hee Noh, Songhee Han, Haeri Lee, Chang Seok Lee, Dong-Sup Lee, Sang-Kyu Ye,[...]. Biochem Pharmacol 2013
26
50


circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway.
Yutang Huang, Yi Dai, Chunjie Wen, Shuai He, Jingjing Shi, Dezhang Zhao, Lanxiang Wu, Honghao Zhou. Mol Ther Nucleic Acids 2020
7
50

Osimertinib (AZD9291) Attenuates the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCB1 in Vitro.
Sung-Han Hsiao, Yu-Jen Lu, Yan-Qing Li, Yang-Hui Huang, Chia-Hung Hsieh, Chung-Pu Wu. Mol Pharm 2016
28
50

Antimicrobial effect of sophoraflavanone G isolated from Sophora flavescens against mutans streptococci.
Chun Sung Kim, Soon-Nang Park, Sug-Joon Ahn, Young-Woo Seo, Young-Ju Lee, Yun Kyong Lim, Marcelo Oliveira Freire, Eugene Cho, Joong-Ki Kook. Anaerobe 2013
14
50

Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2.
Bin Ke, Ting Wei, Yuanyuan Huang, Yuxin Gong, Gang Wu, Junfang Liu, Xiaoting Chen, Lin Shi. Mediators Inflamm 2019
13
50

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis.
Lina Tang, Chunling Zhang, Hairong He, Zhenyu Pan, Di Fan, Yinli He, Haisheng You, Yuanjie Li. Onco Targets Ther 2018
6
50

Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.
Kiyotaka Yoh, Genichiro Ishii, Tomoyuki Yokose, Yuji Minegishi, Kohji Tsuta, Koichi Goto, Yutaka Nishiwaki, Tetsuro Kodama, Moritaka Suga, Atsushi Ochiai. Clin Cancer Res 2004
176
50

Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.
Chung-Pu Wu, Shinobu Ohnuma, Suresh V Ambudkar. Curr Pharm Biotechnol 2011
107
50


Protective effect of Sophoraflavanone G on streptozotocin (STZ)-induced inflammation in diabetic rats.
Hanqing Wang, Li Chen, Liming Zhang, Xiaojuan Gao, Yinghua Wang, Tao Weiwei. Biomed Pharmacother 2016
2
50

Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.
Petra Hoffknecht, Amanda Tufman, Thomas Wehler, Theo Pelzer, Rainer Wiewrodt, Martin Schütz, Monika Serke, Jan Stöhlmacher-Williams, Angela Märten, Rudolf Maria Huber,[...]. J Thorac Oncol 2015
182
50

Anti-inflammatory effect of sophoraflavanone G isolated from Sophora flavescens in lipopolysaccharide-stimulated mouse macrophages.
Zih-Yi Wun, Chwan-Fwu Lin, Wen-Chung Huang, Yu-Ling Huang, Pei-Yin Xu, Wei-Tien Chang, Shu-Ju Wu, Chian-Jiun Liou. Food Chem Toxicol 2013
23
50

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Chun-ling Dai, Amit K Tiwari, Chung-Pu Wu, Xiao-Dong Su, Si-Rong Wang, Dong-geng Liu, Charles R Ashby, Yan Huang, Robert W Robey, Yong-ju Liang,[...]. Cancer Res 2008
299
50

The effect of co-administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco-2 cell monolayers.
Walter Brand, Beatriz Padilla, Peter J van Bladeren, Gary Williamson, Ivonne M C M Rietjens. Mol Nutr Food Res 2010
37
50

A multidrug resistance transporter from human MCF-7 breast cancer cells.
L A Doyle, W Yang, L V Abruzzo, T Krogmann, Y Gao, A K Rishi, D D Ross. Proc Natl Acad Sci U S A 1998
50

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines.
Maricla Galetti, Pier Giorgio Petronini, Claudia Fumarola, Daniele Cretella, Silvia La Monica, Mara Bonelli, Andrea Cavazzoni, Francesca Saccani, Cristina Caffarra, Roberta Andreoli,[...]. PLoS One 2015
39
50

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter.
Csilla Ozvegy-Laczka, Tamás Hegedus, György Várady, Olga Ujhelly, John D Schuetz, András Váradi, György Kéri, László Orfi, Katalin Német, Balázs Sarkadi. Mol Pharmacol 2004
259
50

Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines.
Chung-Pu Wu, Sung-Han Hsiao, Megumi Murakami, Ming-Jie Lu, Yan-Qing Li, Chia-Hung Hsieh, Suresh V Ambudkar, Yu-Shan Wu. Cancer Lett 2017
12
50

KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer.
Luca Jaromi, Veronika Csongei, Monika Vesel, ElHusseiny Mohamed Mahmud Abdelwahab, Amina Soltani, Zsofia Torok, Gabor Smuk, Veronika Sarosi, Judit Erzsebet Pongracz. Int J Mol Sci 2021
1
100

A Systematic Review of Recently Reported Marine Derived Natural Product Kinase Inhibitors.
Te Li, Ning Wang, Ting Zhang, Bin Zhang, Thavarool P Sajeevan, Valsamma Joseph, Lorene Armstrong, Shan He, Xiaojun Yan, C Benjamin Naman. Mar Drugs 2019
18
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.